As of January 22, 2025, Galenica (GALE.SW) has a market cap of $4.35 billion USD. According to our data, Galenica is ranked No.2899 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $4.35 B |
6.25%
|
Dec 30, 2024 | $4.09 B |
5.39%
|
Dec 29, 2023 | $3.88 B |
-0.96%
|
Dec 30, 2022 | $3.92 B |
13.43%
|
Dec 30, 2021 | $3.45 B |
19.54%
|
Dec 30, 2020 | $2.89 B |
1.10%
|
Dec 30, 2019 | $2.86 B |
43.05%
|
Dec 28, 2018 | $2.00 B |
-10.85%
|
Dec 29, 2017 | $2.24 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Roche
ROG.SW
|
$243.91 B |
38.073 B
|
Switzerland
|
Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
Sanofi
SNY
|
$128.55 B |
0.003 M
|
France
|
Bayer
BAYN.DE
|
$21.48 B |
-0.001 M
|
Germany
|
Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.38 B |
0.002 M
|
UK
|
AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
AbbVie
ABBV
|
$300.53 B |
0.002 M
|
USA
|
Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
Teva Pharmaceutical Industries
TEVA
|
$25.08 B |
19.908 M
|
Israel
|
Novo Nordisk
NVO
|
$335.53 B |
64.154 B
|
Denmark
|
Market Cap | = | GALE.SW Stock Price | * | GALE.SW Shares Outstanding |
= | $87.21 | * | 49.83 M | |
= | $4.35 B |